A carregar...
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
The efficacy of standard antidepressants is limited for many patients with mood disorders such as major depressive disorder (MDD) and bipolar depression, underscoring the urgent need to develop novel therapeutics. Both clinical and preclinical studies have implicated glutamatergic system dysfunction...
Na minha lista:
| Publicado no: | CNS Drugs |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8201267/ https://ncbi.nlm.nih.gov/pubmed/33904154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-021-00816-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|